glp-1 agonists and anesthesia The Impact of Receptor on Sedation The American Society of Anesthesiologists

L-Carnitine converts fat cells into energy by transporting fatty acids into the mitochondria

Niagen is a precursor to NAD+

Proteomic and metabolomic characterization of COVID-19 patient sera

WADA Prohibition While GLP1 and cagrilintide individually have not been explicitly listed by WADA, several considerations apply: GLP-1 agonist precedent Other GLP-1 agonists are monitored for potential misuse in athletics Weight-class sports concern Rapid weight reduction capabilities raise concerns for sports with weight classifications Performance-enhancing potential Metabolic effects could theoretically affect athletic performance Monitoring program possible May be added to WADA monitoring program as use increases Athletes should consult with their sports governing bodies and anti-doping authorities before considering any GLP-1 or amylin analogue use